Steven Canfield, MD

Steven Canfield, MD, examines the innovative use of laser technology for prostate ablation in the management of prostate cancer. Dr. Canfield emphasizes the procedure’s precision, safety, and efficacy, positioning it as a significant advancement in prostate cancer treatment.

Dr. Canfield reviews the mechanisms of laser ablation under real-time imaging guidance, often using ultrasound or MRI. He asserts that this approach allows for the precise targeting of cancerous lesions, reducing the risk of damage to critical anatomical structures such as the neurovascular bundles and urinary sphincter.

Dr. Canfield highlights patient selection criteria and presents clinical outcome data that demonstrates promising results of laser ablation. He addresses the technological advancements that have enhanced the effectiveness and safety of the procedure, including improved imaging techniques and laser delivery systems.